ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2019

Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study.

Yasuo Terauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.